Keloid and Scar Treatment Denied by Insurance? How to Appeal

Keloids and hypertrophic scars develop when the body overproduces collagen during wound healing. They can grow beyond the original wound boundaries, cause chronic pain and itching, restrict movement, and cause significant psychological distress. Insurance companies routinely deny keloid and scar treatments as cosmetic — but for many patients, these scars create functional impairment that clearly meets medical necessity standards. Here is how to build your appeal.

Why Insurers Deny Keloid Treatment

Cosmetic classification: The most common denial. Insurers characterize all scar treatment as cosmetic improvement rather than functional restoration.

Post-surgical scar exclusion: Some policies contain explicit exclusions for complications of cosmetic surgery, which insurers sometimes apply broadly to all post-surgical scars — even when the original surgery was medically necessary.

"Not medically necessary" for adjuvant radiation: Radiation brachytherapy after surgical keloid excision is the most effective keloid treatment, with recurrence rates under 10%. Despite strong evidence, it is frequently denied as experimental or not medically necessary.

Sequence of treatment disputes: Insurers may approve one modality but not another, or dispute the need for multimodal treatment combining several approaches.

The Functional Impairment Argument

To overcome a cosmetic exclusion, your appeal must establish that the keloid or hypertrophic scar causes functional impairment beyond appearance:

Pain and pruritis: Keloids frequently cause chronic neuropathic pain and intense itching. Document pain scores at each visit, use of pain medications or antihistamines specifically for scar-related symptoms, and sleep disruption.

Range of motion restriction: Keloids over joints (shoulder, knee, elbow, finger) or across flexion surfaces can restrict range of motion. Document with goniometric measurements and comparison to the unaffected contralateral side.

Burn scar contractures: Post-burn hypertrophic scars are among the most medically accepted scar treatment indications. Document contracture, range of motion limitation, and functional ADL (activities of daily living) impairment.

Traumatic scar origins: Document the injury that caused the scar — motor vehicle accident, workplace injury, assault, or medically necessary surgery. Scars from medically necessary procedures should be explicitly distinguished from cosmetic surgery complications.

Post-surgical scar from necessary procedure: If the keloid developed after medically necessary surgery (appendectomy, C-section, cardiac surgery, cancer excision), document the original procedure's indication and establish that the scar is a medical complication, not a cosmetic problem.

Treatment Modalities and How to Appeal Each

Corticosteroid injections (triamcinolone): First-line keloid treatment, often covered. If denied, document the number of prior injections, response assessment, and clinical rationale for continuing treatment or escalating to other modalities.

Silicone gel sheets and silicone gel: Evidence-based first-line adjuvant therapy. If denied as over-the-counter, note that medical-grade silicone (Mepiform, Scar Away Silicone Gel) is prescribed and applied under physician supervision as part of a scar management protocol.

Laser treatment: Pulsed dye laser (PDL) for vascular keloids, fractional CO2 or erbium for hypertrophic scars. Appeal by documenting steroid injection failure, functional impairment, and AAD-supported laser treatment guidelines.

Surgical excision: Keloid excision alone has high recurrence rates (>50%). Document this in your appeal and argue for post-excision adjuvant treatment.

Radiation brachytherapy post-excision: Superficial radiation therapy (SRT) or brachytherapy immediately after keloid excision dramatically reduces recurrence. If denied as experimental, cite published literature showing 90%+ control rates and include your radiation oncologist's documentation of standard-of-care practice at academic medical centers.

Cryotherapy: Intralesional cryotherapy with a specialized probe is effective for softer keloids. Document as a less invasive alternative to surgery.

Post-Surgical and Post-Trauma Context Documentation

The medical record context of how the scar originated is critical:

• Include surgical operative notes confirming the original procedure was medically necessary
• For trauma: include emergency department or urgent care records from the time of injury
• For burns: include burn unit admission records
• Link the scar treatment directly to the original medically necessary event

AAD and Wound Care Guidelines

The American Academy of Dermatology and wound care society guidelines recognize multimodal keloid treatment — combining intralesional steroids, silicone, pressure therapy, and adjuvant radiation — as evidence-based. Reference these guidelines in your appeal letter.

Fight Back With ClaimBack

ClaimBack's scar treatment appeal framework includes functional impairment documentation templates, cosmetic exclusion rebuttals, and post-excision radiation coverage arguments.

Start your free appeal at ClaimBack

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Common Reasons Insurance Claims Are Denied